Answers are grounded in this paper and cite their sources.
Case details highlight AL amyloidosis presenting with hepatomegaly, suggesting timely chemotherapy improves prognosis.
Light chain (AL) amyloidosis presenting predominantly with hepatomegaly is a rare and frequently misdiagnosed condition. While clinical features are non‐specific, elevated ALP/GGT should raise suspicion. A liver biopsy remains the gold standard for diagnosis. Although there is no disease‐specific therapy for hepatic amyloidosis, timely chemotherapy initiation—particularly monoclonal antibody‐based regimens—can significantly improve prognosis and lead to symptom resolution.
No takes yet. Share an insight, caveat, or question.
Dong et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: